Filing Details

Accession Number:
0001415889-23-000056
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-03 16:30:15
Reporting Period:
2022-12-29
Accepted Time:
2023-01-03 16:30:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673232 Michael Benkowitz C/O United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-29 5,000 $163.30 7,353 No 4 M Direct
Common Stock Disposition 2022-12-29 5,000 $275.99 2,353 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Share Tracking Award Disposition 2022-12-29 5,000 $0.00 5,000 $163.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,200 2016-03-13 2025-03-13 No 4 M Direct
Footnotes
  1. This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
  2. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.